These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 33382730

  • 1. Preliminary validation of the use of IgG antibody response to Anopheles gSG6-p1 salivary peptide to assess human exposure to malaria vector bites in two endemic areas of Cameroon in Central Africa.
    Cheteug G, Elanga-Ndille E, Donkeu C, Ekoko W, Oloume M, Essangui E, Nwane P, NSango SE, Etang J, Wanji S, Ayong L, Eboumbou Moukoko CE.
    PLoS One; 2020; 15(12):e0242510. PubMed ID: 33382730
    [Abstract] [Full Text] [Related]

  • 2. Utility of plasma anti-gSG6-P1 IgG levels in determining changes in Anopheles gambiae bite rates in a rural area of Cameroon.
    Nguetsa GC, Elanga-Ndille E, Essangui Same EG, Nganso Keptchouang T, Mandeng SE, Ekoko Eyisap W, Binyang JA, Fogang B, Nouage L, Piameu M, Ayong L, Etang J, Wanji S, Eboumbou Moukoko CE.
    Sci Rep; 2024 Jun 21; 14(1):14294. PubMed ID: 38906949
    [Abstract] [Full Text] [Related]

  • 3. IgG antibody responses to Anopheles gambiae gSG6-P1 salivary peptide are induced in human populations exposed to secondary malaria vectors in forest areas in Cameroon.
    Ndo C, Elanga-Ndille E, Cheteug G, Metitsi RD, Wanji S, Moukoko CEE.
    PLoS One; 2022 Jun 21; 17(11):e0276991. PubMed ID: 36355922
    [Abstract] [Full Text] [Related]

  • 4. Plasmodium falciparum infection during dry season: IgG responses to Anopheles gambiae salivary gSG6-P1 peptide as sensitive biomarker for malaria risk in Northern Senegal.
    Sagna AB, Gaayeb L, Sarr JB, Senghor S, Poinsignon A, Boutouaba-Combe S, Schacht AM, Hermann E, Faye N, Remoue F, Riveau G.
    Malar J; 2013 Aug 30; 12():301. PubMed ID: 23988032
    [Abstract] [Full Text] [Related]

  • 5. Exploring the heterogeneity of human exposure to malaria vectors in an urban setting, Bouaké, Côte d'Ivoire, using an immuno-epidemiological biomarker.
    Traoré DF, Sagna AB, Adja AM, Zoh DD, Adou KA, Lingué KN, Coulibaly I, Tchiekoi NB, Assi SB, Poinsignon A, Dagnogo M, Remoue F.
    Malar J; 2019 Mar 11; 18(1):68. PubMed ID: 30857543
    [Abstract] [Full Text] [Related]

  • 6. gSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areas.
    Sagna AB, Sarr JB, Gaayeb L, Drame PM, Ndiath MO, Senghor S, Sow CS, Poinsignon A, Seck M, Hermann E, Schacht AM, Faye N, Sokhna C, Remoue F, Riveau G.
    Parasit Vectors; 2013 Mar 15; 6():68. PubMed ID: 23497646
    [Abstract] [Full Text] [Related]

  • 7. Variation in exposure to Anopheles gambiae salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands.
    Badu K, Siangla J, Larbi J, Lawson BW, Afrane Y, Ong'echa J, Remoue F, Zhou G, Githeko AK, Yan G.
    Malar J; 2012 Sep 10; 11():318. PubMed ID: 22963464
    [Abstract] [Full Text] [Related]

  • 8. IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.
    Drame PM, Machault V, Diallo A, Cornélie S, Poinsignon A, Lalou R, Sembène M, Dos Santos S, Rogier C, Pagès F, Le Hesran JY, Remoué F.
    Malar J; 2012 Mar 16; 11():72. PubMed ID: 22424570
    [Abstract] [Full Text] [Related]

  • 9. IgG antibody response against Anopheles salivary gland proteins in asymptomatic Plasmodium infections in Narino, Colombia.
    Montiel J, Carbal LF, Tobón-Castaño A, Vásquez GM, Fisher ML, Londono-Rentería B.
    Malar J; 2020 Jan 23; 19(1):42. PubMed ID: 31973737
    [Abstract] [Full Text] [Related]

  • 10. Anopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.
    Ya-Umphan P, Cerqueira D, Cottrell G, Parker DM, Fowkes FJI, Nosten F, Corbel V.
    Am J Trop Med Hyg; 2018 Aug 23; 99(2):350-356. PubMed ID: 29869601
    [Abstract] [Full Text] [Related]

  • 11. Human IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bites.
    Poinsignon A, Cornelie S, Ba F, Boulanger D, Sow C, Rossignol M, Sokhna C, Cisse B, Simondon F, Remoue F.
    Malar J; 2009 Aug 13; 8():198. PubMed ID: 19674487
    [Abstract] [Full Text] [Related]

  • 12. An. gambiae gSG6-P1 evaluation as a proxy for human-vector contact in the Americas: a pilot study.
    Londono-Renteria B, Drame PM, Weitzel T, Rosas R, Gripping C, Cardenas JC, Alvares M, Wesson DM, Poinsignon A, Remoue F, Colpitts TM.
    Parasit Vectors; 2015 Oct 13; 8():533. PubMed ID: 26464073
    [Abstract] [Full Text] [Related]

  • 13. Spatial Assessment of Contact Between Humans and Anopheles and Aedes Mosquitoes in a Medium-Sized African Urban Setting, Using Salivary Antibody-Based Biomarkers.
    Sagna AB, Kassié D, Couvray A, Adja AM, Hermann E, Riveau G, Salem G, Fournet F, Remoue F.
    J Infect Dis; 2019 Aug 30; 220(7):1199-1208. PubMed ID: 31152664
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of Malaria Urban Risk Using an Immuno-Epidemiological Biomarker of Human Exposure to Anopheles Bites.
    Traoré DF, Sagna AB, Adja AM, Zoh DD, Lingué KN, Coulibaly I, N'Cho Tchiekoi B, Assi SB, Poinsignon A, Dagnogo M, Remoue F.
    Am J Trop Med Hyg; 2018 May 30; 98(5):1353-1359. PubMed ID: 29512479
    [Abstract] [Full Text] [Related]

  • 15. Human IgG responses to Aedes mosquito salivary peptide Nterm-34kDa and its comparison to Anopheles salivary antigen (gSG6-P1) IgG responses measured among individuals living in Lower Moshi, Tanzania.
    Kassam NA, Laswai D, Kulaya N, Kaaya RD, Kajeguka DC, Schmiegelow C, Wang CW, Alifrangis M, Kavishe RA.
    PLoS One; 2022 May 30; 17(10):e0276437. PubMed ID: 36301860
    [Abstract] [Full Text] [Related]

  • 16. Use of anti-gSG6-P1 IgG as a serological biomarker to assess temporal exposure to Anopheles' mosquito bites in Lower Moshi.
    Kassam NA, Kulaya N, Kaaya RD, Schmiegelow C, Wang CW, Kavishe RA, Alifrangis M.
    PLoS One; 2021 May 30; 16(10):e0259131. PubMed ID: 34705869
    [Abstract] [Full Text] [Related]

  • 17. Wide cross-reactivity between Anopheles gambiae and Anopheles funestus SG6 salivary proteins supports exploitation of gSG6 as a marker of human exposure to major malaria vectors in tropical Africa.
    Rizzo C, Ronca R, Fiorentino G, Mangano VD, Sirima SB, Nèbiè I, Petrarca V, Modiano D, Arcà B.
    Malar J; 2011 Jul 27; 10():206. PubMed ID: 21794142
    [Abstract] [Full Text] [Related]

  • 18. Human exposure to Anopheles farauti bites in the Solomon Islands is not associated with IgG antibody response to the gSG6 salivary protein of Anopheles gambiae.
    Pollard EJM, Patterson C, Russell TL, Apairamo A, Oscar J, Arcà B, Drakeley C, Burkot TR.
    Malar J; 2019 Oct 01; 18(1):334. PubMed ID: 31570113
    [Abstract] [Full Text] [Related]

  • 19. Uneven malaria transmission in geographically distinct districts of Bobo-Dioulasso, Burkina Faso.
    Soma DD, Kassié D, Sanou S, Karama FB, Ouari A, Mamai W, Ouédraogo GA, Salem G, Dabiré RK, Fournet F.
    Parasit Vectors; 2018 May 11; 11(1):296. PubMed ID: 29751825
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the effectiveness of malaria vector control measures in urban settings of Dakar by a specific anopheles salivary biomarker.
    Drame PM, Diallo A, Poinsignon A, Boussari O, Dos Santos S, Machault V, Lalou R, Cornelie S, LeHesran JY, Remoue F.
    PLoS One; 2013 May 11; 8(6):e66354. PubMed ID: 23840448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.